Equities
  • Price (EUR)479.50
  • Today's Change-3.80 / -0.79%
  • Shares traded20.00
  • 1 Year change-8.21%
  • Beta1.0225
Data delayed at least 15 minutes, as of Jun 30 2025 16:25 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Roper Technologies, Inc. is a diversified technology company. It operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. The Company operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Procare, Strata, Transact/CBORD, and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS, and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. Data Innovations is a software solution that enables the enterprise management of hospitals and independent laboratories.

  • Revenue in USD (TTM)7.24bn
  • Net income in USD1.50bn
  • Incorporated1981
  • Employees18.20k
  • Location
    Roper Technologies Inc6496 University ParkwaySARASOTA 34240United StatesUSA
  • Phone+1 (941) 556-2601
  • Fax+1 (941) 556-2670
  • Websitehttps://www.ropertech.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ROP:NSQ since
announced
Transaction
value
CentralReach LLCDeal completed24 Mar 202524 Mar 2025Deal completed-0.93%1.65bn
Transact Campus IncDeal completed15 Aug 202415 Aug 2024Deal completed7.36%1.61bn
Data delayed at least 15 minutes, as of Jun 30 2025 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.